Grifols SA (GIFLF)
12.72
0.00 (0.00%)
USD |
OTCM |
Nov 17, 16:00
Grifols Total Assets (Quarterly) : 23.04B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 23.04B |
| June 30, 2026 | 22.97B |
| March 31, 2026 | 23.13B |
| December 31, 2025 | 23.20B |
| September 30, 2025 | 23.33B |
| June 30, 2025 | 23.20B |
| March 31, 2025 | 22.66B |
| December 31, 2024 | 22.18B |
| September 30, 2024 | 22.64B |
| June 30, 2024 | 23.89B |
| March 31, 2024 | 23.71B |
| December 31, 2023 | 23.20B |
| September 30, 2023 | 23.36B |
| June 30, 2023 | 23.38B |
| March 31, 2023 | 23.20B |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | 18.97B |
| December 31, 2020 | 18.69B |
| September 30, 2020 | 18.35B |
| Date | Value |
|---|---|
| June 30, 2020 | 17.52B |
| March 31, 2020 | 17.44B |
| December 31, 2019 | 17.45B |
| September 30, 2019 | 15.30B |
| June 30, 2019 | 15.17B |
| March 31, 2019 | 15.03B |
| December 31, 2018 | 14.26B |
| September 30, 2018 | 13.68B |
| June 30, 2018 | 13.35B |
| March 31, 2018 | 13.38B |
| December 31, 2017 | 13.11B |
| September 30, 2017 | 13.02B |
| June 30, 2017 | 12.68B |
| March 31, 2017 | 12.52B |
| December 31, 2016 | 10.68B |
| September 30, 2016 | 10.75B |
| June 30, 2016 | 10.60B |
| March 31, 2016 | 10.53B |
| December 31, 2015 | 10.43B |
| September 30, 2015 | 10.25B |
| June 30, 2015 | 10.13B |
| March 31, 2015 | 10.07B |
| December 31, 2014 | 10.22B |
| September 30, 2014 | 10.24B |
| June 30, 2014 | 9.962B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pharma Mar SA | 463.88M |
| Oryzon Genomics SA | 192.52M |
| Agenus, Inc. | 245.55M |
| Amgen, Inc. | 96.05B |
| Anika Therapeutics, Inc. | 189.60M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.67B |
| Shareholders Equity (Quarterly) | 6.574B |
| Debt to Equity Ratio | 1.596 |
| Current Ratio | 2.329 |
| Net Debt Paydown Yield | 0.02% |